SYS-CON MEDIA Authors: Carmen Gonzalez, Yeshim Deniz, Nikita Ivanov, Sean Houghton, Glenn Rossman

News Feed Item

Influenza Global Clinical Trials Review, H2, 2013



 

 

 

LONDON, March 19, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

Influenza Global Clinical Trials Review, H2, 2013


Influenza Global Clinical Trials Review, H2, 2013


Summary

GlobalData's clinical trial report, "Influenza Global Clinical Trials Review, H2, 2013" provides data on the Influenza clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Influenza. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Influenza. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)


Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Influenza 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Influenza 24
Subjects Recruited Over a Period of Time 31
Prominent Sponsors 32
Top Companies Participating in Influenza Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Novartis AG 49
Clinical Trial Overview of Novartis AG 49
Sanofi 56
Clinical Trial Overview of Sanofi 56
MedImmune, LLC 61
Clinical Trial Overview of MedImmune, LLC 61
F. Hoffmann-La Roche Ltd. 65
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 65
CSL Limited 67
Clinical Trial Overview of CSL Limited 67
Baxter International Inc. 69
Clinical Trial Overview of Baxter International Inc. 69
Daiichi Sankyo Company, Limited 71
Clinical Trial Overview of Daiichi Sankyo Company, Limited 71
Crucell Holland B.V 72
Clinical Trial Overview of Crucell Holland B.V 72
BioCryst Pharmaceuticals, Inc. 73
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 73
Adimmune Corporation 74
Clinical Trial Overview of Adimmune Corporation 74
Sinovac Biotech Co., Ltd. 75
Clinical Trial Overview of Sinovac Biotech Co., Ltd. 75
OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd. 76
Clinical Trial Overview of OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd. 76
Novartis Vaccines and Diagnostics, Inc. 77
Clinical Trial Overview of Novartis Vaccines and Diagnostics, Inc. 77
Novavax, Inc. 78
Clinical Trial Overview of Novavax, Inc. 78
VaxInnate Corporation 79
Clinical Trial Overview of VaxInnate Corporation 79
Protein Sciences Corporation 80
Clinical Trial Overview of Protein Sciences Corporation 80
Abbott Laboratories 81
Clinical Trial Overview of Abbott Laboratories 81
Kaketsuken K.K. 82
Clinical Trial Overview of Kaketsuken K.K. 82
Pfizer Inc. 83
Clinical Trial Overview of Pfizer Inc. 83
Clinical Trial Overview of Top Institutes / Government 84
The National Institute of Allergy and Infectious Diseases 84
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 84
The University of Hong Kong 91
Clinical Trial Overview of The University of Hong Kong 91
University of Oxford 92
Clinical Trial Overview of University of Oxford 92
University Hospitals of Leicester NHS Trust 93
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 93
National Hospital Organization Mie National Hospital 94
Clinical Trial Overview of National Hospital Organization Mie National Hospital 94
Centers for Disease Control and Prevention 95
Clinical Trial Overview of Centers for Disease Control and Prevention 95
St. Jude Children's Research Hospital, Inc. 96
Clinical Trial Overview of St. Jude Children's Research Hospital, Inc. 96
The University of British Columbia 97
Clinical Trial Overview of The University of British Columbia 97
University of the Witwatersrand 98
Clinical Trial Overview of University of the Witwatersrand 98
Program for Appropriate Technology in Health 99
Clinical Trial Overview of Program for Appropriate Technology in Health 99
University of Rochester 100
Clinical Trial Overview of University of Rochester 100
Columbia University 101
Clinical Trial Overview of Columbia University 101
Assistance Publique - Hopitaux de Paris 102
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 102
McMaster University 103
Clinical Trial Overview of McMaster University 103
Institut National de la Sante et de la Recherche Medicale 104
Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 104
Queen Mary Hospital 105
Clinical Trial Overview of Queen Mary Hospital 105
University of Pittsburgh 106
Clinical Trial Overview of University of Pittsburgh 106
Hadassah Medical Organization 107
Clinical Trial Overview of Hadassah Medical Organization 107
University of Michigan 108
Clinical Trial Overview of University of Michigan 108
University of Alberta 109
Clinical Trial Overview of University of Alberta 109
Five Key Clinical Profiles 110
Appendix 161
Abbreviations 161
Definitions 161
Research Methodology 162
Secondary Research 162
About GlobalData 163
Contact Us 163
Disclaimer 163
Source 164




List of Tables

Influenza Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Influenza Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Influenza Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Influenza Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Influenza Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Influenza Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Influenza Therapeutics Clinical Trials, G7 Countries, 2013* 17
Influenza Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Influenza Therapeutics Clinical Trials, E7 Countries, 2013* 19
Influenza Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Influenza Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Influenza Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Influenza Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Influenza Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Influenza Therapeutics Market, Global, Terminated Clinical Trials, 2013* 27
Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 31
Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 33
Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 35
Influenza Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 37
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 49
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 56
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2013* 61
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 65
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2013* 67
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2013* 69
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2013* 71
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Crucell Holland B.V, 2013* 72
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2013* 73
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Adimmune Corporation, 2013* 74
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Sinovac Biotech Co., Ltd., 2013* 75
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd., 2013* 76
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Vaccines and Diagnostics, Inc., 2013* 77
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Novavax, Inc., 2013* 78
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by VaxInnate Corporation, 2013* 79
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Protein Sciences Corporation, 2013* 80
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2013* 81
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaketsuken K.K., 2013* 82
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 83
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 84
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2013* 91
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2013* 92
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2013* 93
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by National Hospital Organization Mie National Hospital, 2013* 94
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2013* 95
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, Inc., 2013* 96
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of British Columbia, 2013* 97
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of the Witwatersrand, 2013* 98
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Program for Appropriate Technology in Health, 2013* 99
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2013* 100
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2013* 101
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 102
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2013* 103
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut National de la Sante et de la Recherche Medicale, 2013* 104
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary Hospital, 2013* 105
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 106
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2013* 107
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2013* 108
Influenza Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2013* 109

List of Figures
Influenza Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Influenza Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Influenza Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Influenza Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Influenza Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
Influenza Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Influenza Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Influenza Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Influenza Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Influenza Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Influenza Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Influenza Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Influenza Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 31
Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 32
Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 34
Influenza Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36
GlobalData Methodology 162


Read the full report:
Influenza Global Clinical Trials Review, H2, 2013
http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trial...

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Gridstore™, the leader in hyper-converged infrastructure purpose-built to optimize Microsoft workloads, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Gridstore™ is the leader in hyper-converged infrastructure purpose-built for Microsoft workloads and designed to accelerate applications in virtualized environments. Gridstore’s hyper-converged infrastructure is the ...
The 3rd International @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that it is now accepting Keynote Proposals. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devices - computers, smartphones, tablets, and sensors - connected to th...
"There is a natural synchronization between the business models, the IoT is there to support ,” explained Brendan O'Brien, Co-founder and Chief Architect of Aria Systems, in this SYS-CON.tv interview at the 15th International Cloud Expo®, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
Fundamentally, SDN is still mostly about network plumbing. While plumbing may be useful to tinker with, what you can do with your plumbing is far more intriguing. A rigid interpretation of SDN confines it to Layers 2 and 3, and that's reasonable. But SDN opens opportunities for novel constructions in Layers 4 to 7 that solve real operational problems in data centers. "Data center," in fact, might become anachronistic - data is everywhere, constantly on the move, seemingly always overflowing. Net...
An entirely new security model is needed for the Internet of Things, or is it? Can we save some old and tested controls for this new and different environment? In his session at @ThingsExpo, New York's at the Javits Center, Davi Ottenheimer, EMC Senior Director of Trust, reviewed hands-on lessons with IoT devices and reveal a new risk balance you might not expect. Davi Ottenheimer, EMC Senior Director of Trust, has more than nineteen years' experience managing global security operations and asse...
The 4th International DevOps Summit, co-located with16th International Cloud Expo – being held June 9-11, 2015, at the Javits Center in New York City, NY – announces that its Call for Papers is now open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's large...
SYS-CON Media announced that Centrify, a provider of unified identity management across cloud, mobile and data center environments that delivers single sign-on (SSO) for users and a simplified identity infrastructure for IT, has launched an ad campaign on Cloud Computing Journal. The ads focus on security: how an organization can successfully control privilege for all of the organization’s identities to mitigate identity-related risk without slowing down the business, and how Centrify provides ...
The Internet of Things promises to transform businesses (and lives), but navigating the business and technical path to success can be difficult to understand. In his session at @ThingsExpo, Sean Lorenz, Technical Product Manager for Xively at LogMeIn, demonstrated how to approach creating broadly successful connected customer solutions using real world business transformation studies including New England BioLabs and more.
There's Big Data, then there's really Big Data from the Internet of Things. IoT is evolving to include many data possibilities like new types of event, log and network data. The volumes are enormous, generating tens of billions of logs per day, which raise data challenges. Early IoT deployments are relying heavily on both the cloud and managed service providers to navigate these challenges. In her session at Big Data Expo®, Hannah Smalltree, Director at Treasure Data, discussed how IoT, Big D...
The Internet of Things will greatly expand the opportunities for data collection and new business models driven off of that data. In her session at @ThingsExpo, Esmeralda Swartz, CMO of MetraTech, discussed how for this to be effective you not only need to have infrastructure and operational models capable of utilizing this new phenomenon, but increasingly service providers will need to convince a skeptical public to participate. Get ready to show them the money!
The 3rd International Internet of @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that its Call for Papers is now open. The Internet of Things (IoT) is the biggest idea since the creation of the Worldwide Web more than 20 years ago.
In her General Session at 15th Cloud Expo, Anne Plese, Senior Consultant, Cloud Product Marketing, at Verizon Enterprise, focused on finding the right mix of renting vs. buying Oracle capacity to scale to meet business demands, and offer validated Oracle database TCO models for Oracle development and testing environments. Anne Plese is a marketing and technology enthusiast/realist with over 19+ years in high tech. At Verizon Enterprise, she focuses on driving growth for the Verizon Cloud platfo...
SYS-CON Events announced today Isomorphic Software, the global leader in high-end, web-based business applications, will exhibit at SYS-CON's DevOps Summit 2015 New York, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Isomorphic Software is the global leader in high-end, web-based business applications. We develop, market, and support the SmartClient & Smart GWT HTML5/Ajax platform, combining the productivity and performance of traditional desktop software ...
The Internet of Things will put IT to its ultimate test by creating infinite new opportunities to digitize products and services, generate and analyze new data to improve customer satisfaction, and discover new ways to gain a competitive advantage across nearly every industry. In order to help corporate business units to capitalize on the rapidly evolving IoT opportunities, IT must stand up to a new set of challenges. In his session at @ThingsExpo, Jeff Kaplan, Managing Director of THINKstrateg...
The Internet of Things is tied together with a thin strand that is known as time. Coincidentally, at the core of nearly all data analytics is a timestamp. When working with time series data there are a few core principles that everyone should consider, especially across datasets where time is the common boundary. In his session at Internet of @ThingsExpo, Jim Scott, Director of Enterprise Strategy & Architecture at MapR Technologies, discussed single-value, geo-spatial, and log time series dat...